Cargando…
Bortezomib protects against dextran sulfate sodium-induced ulcerative colitis in mice
Bortezomib, a first-in-class proteasome inhibitor, is a standard method of treatment in multiple myeloma. In the present study, the therapeutic effect of bortezomib was evaluated in an ulcerative colitis model induced by dextran sulfate sodium (DSS) in mice, and the mechanism of action was also inve...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436237/ https://www.ncbi.nlm.nih.gov/pubmed/28487944 http://dx.doi.org/10.3892/mmr.2017.6524 |